Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation (Q39507582)

12 September 2017

title

Synthesis and evaluation of bifunctional anti-HIV agents based on specific CXCR4 antagonists-AZT conjugation (English)

1 reference

12 September 2017

Tamamura H

1

1 reference

12 September 2017

Omagari A

2

1 reference

12 September 2017

Hiramatsu K

3

1 reference

12 September 2017

Kanamoto T

4

1 reference

12 September 2017

Gotoh K

5

1 reference

12 September 2017

Kanbara K

6

1 reference

12 September 2017

Yamamoto N

7

1 reference

12 September 2017

Nakashima H

8

1 reference

12 September 2017

Otaka A

9

1 reference

12 September 2017

Fujii N

10

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Bioorganic & Medicinal Chemistry

12 September 2017

published in

1 reference

12 September 2017

volume

9

1 reference

12 September 2017

issue

8

1 reference

12 September 2017

page(s)

2179-2187

1 reference

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

HIV blocked by chemokine antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Membrane permeation mechanisms of 2',3'-dideoxynucleosides

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

A new class of anti-HIV agents: synthesis and activity of conjugates of HIV protease inhibitors with a reverse transcriptase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

'Double-Drugs'--a new class of prodrug form of an HIV protease inhibitor conjugated with a reverse transcriptase inhibitor by a spontaneously cleavable linker

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

Purification and characterization of an avian myeloblastosis and human immunodeficiency virus reverse transcriptase inhibitor, sulfated polysaccharides extracted from sea algae

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2801%2900128-6

7 January 2021

10.1016/S0968-0896(01)00128-6

Identifiers

DOI

1 reference

12 September 2017

1 reference